AAMU
VRTX icon

Amundi Asset Management US’s Vertex Pharmaceuticals VRTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$208M Buy
969,069
+151,980
+19% +$32.7M 0.16% 150
2020
Q4
$193M Buy
817,089
+382,197
+88% +$90.3M 0.16% 137
2020
Q3
$118M Sell
434,892
-20,732
-5% -$5.64M 0.12% 169
2020
Q2
$132M Sell
455,624
-69,738
-13% -$20.2M 0.16% 132
2020
Q1
$125M Buy
525,362
+243,643
+86% +$58M 0.22% 94
2019
Q4
$61.7M Sell
281,719
-5,237
-2% -$1.15M 0.07% 270
2019
Q3
$48.6M Sell
286,956
-16,829
-6% -$2.85M 0.07% 289
2019
Q2
$55.7M Buy
303,785
+32,290
+12% +$5.92M 0.05% 295
2019
Q1
$49.9M Buy
271,495
+70,337
+35% +$12.9M 0.07% 282
2018
Q4
$33.3K Sell
201,158
-8,922
-4% -$1.48K 0.03% 324
2018
Q3
$40.5M Buy
210,080
+14,324
+7% +$2.76M 0.05% 332
2018
Q2
$33.3M Sell
195,756
-1,078,358
-85% -$183M 0.05% 375
2018
Q1
$208M Sell
1,274,114
-13,932
-1% -$2.27M 0.33% 77
2017
Q4
$193M Buy
1,288,046
+16,370
+1% +$2.45M 0.3% 79
2017
Q3
$193M Sell
1,271,676
-55,081
-4% -$8.37M 0.62% 46
2017
Q2
$171M Sell
1,326,757
-192,065
-13% -$24.8M 0.56% 51
2017
Q1
$166M Buy
1,518,822
+292,664
+24% +$32M 0.56% 49
2016
Q4
$90.3M Sell
1,226,158
-4,934
-0.4% -$363K 0.32% 77
2016
Q3
$107M Buy
1,231,092
+119,298
+11% +$10.4M 0.39% 69
2016
Q2
$95.6M Buy
1,111,794
+235,024
+27% +$20.2M 0.35% 78
2016
Q1
$69.7M Buy
876,770
+109,445
+14% +$8.7M 0.26% 91
2015
Q4
$96.6M Buy
767,325
+96,545
+14% +$12.1M 0.36% 79
2015
Q3
$69.9M Sell
670,780
-74,338
-10% -$7.74M 0.29% 96
2015
Q2
$92M Sell
745,118
-49,129
-6% -$6.07M 0.34% 85
2015
Q1
$93.7M Buy
794,247
+146,990
+23% +$17.3M 0.34% 90
2014
Q4
$76.9M Sell
647,257
-14,556
-2% -$1.73M 0.28% 101
2014
Q3
$74.3M Sell
661,813
-188,339
-22% -$21.2M 0.28% 109
2014
Q2
$80.5M Sell
850,152
-345,803
-29% -$32.7M 0.31% 94
2014
Q1
$84.6M Sell
1,195,955
-20,644
-2% -$1.46M 0.32% 93
2013
Q4
$90.4M Sell
1,216,599
-23,023
-2% -$1.71M 0.35% 91
2013
Q3
$94M Buy
1,239,622
+131,662
+12% +$9.98M 0.38% 79
2013
Q2
$88.5M Buy
+1,107,960
New +$88.5M 0.37% 82